Provide the accounting for the following:
Stanford University medical researchers conducted a study on the correlation between
the use of fertility drugs and ovarian cancer. Their study, published in the American
Journal of Epidemiology, concludes that the use of the fertility drugs, Pergonal and
Serophene, may increase the risk of ovarian cancer by three times. The lead author of
the studies, Professor Alice Whittemore, stated, “Our finding in regard to fertility drugs
is by no means certain. It is based on very small numbers and is really very tenuous.”
FDA Commissioner David Kessler would like the infertility drug manufacturers to
disclose the study findings and offer a warning on the drug packages. He notes, “Even
though the epidemiology study is still preliminary, women have a right to know what is
known. We’re not looking to make more of this than there is.”
If you were a manufacturer of one of the drugs, would you voluntarily disclose the
study information?